Home/Filings/4/0001562180-23-001799
4//SEC Filing

Birkett Bernard 4

Accession 0001562180-23-001799

CIK 0000105770other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 6:30 PM ET

Size

10.1 KB

Accession

0001562180-23-001799

Insider Transaction Report

Form 4
Period: 2023-02-21
Birkett Bernard
Sr VP, Chief Financial Officer
Transactions
  • Award

    Common Stock

    2023-02-21$306.68/sh+3,614$1,108,3424,409 total
  • Award

    Stock Options (Right to buy)

    2023-02-21+10,34010,340 total
    Exercise: $306.68From: 2024-02-21Exp: 2033-02-21Stock Options (Right to Buy) (10,340 underlying)
Footnotes (2)
  • [F1]2020 PSUs (PP19) award vesting net of taxes withheld
  • [F2]This award vests in four equal annual installments beginning on February 21, 2024.

Issuer

WEST PHARMACEUTICAL SERVICES INC

CIK 0000105770

Entity typeother

Related Parties

1
  • filerCIK 0001658001

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 6:30 PM ET
Size
10.1 KB